NeuroPace (NPCE) FCF Margin (2020 - 2026)
NeuroPace's (NPCE) quarterly FCF Margin came in at 27.27% in Q1 2026, up 620.0% year-on-year from 3.79% in Q1 2025, and down 1898.86% quarter-over-quarter from 1.52% in Q4 2025.
NeuroPace (NPCE) FCF Margin (2020 - 2026) Analysis & Trends
NeuroPace's FCF Margin history runs 7 years deep, the most recent figure standing at 27.27% for Q1 2026.
- On a quarterly basis, FCF Margin rose 620.0% year-over-year to 27.27% in Q1 2026; TTM through Mar 2026 was 9.86%, a 1138.0% increase from a year earlier, with the FY2025 full-year figure at 11.33%, up 1109.0% from the prior year.
- FCF Margin retreated to 27.27% in Q1 2026 per NPCE's latest filing, from 1.52% in the prior quarter.
- Across five years, FCF Margin topped out at 1.52% in Q4 2025 and bottomed at 109.21% in Q2 2022.
- The 5-year median for FCF Margin is 26.66% (2023), against an average of 37.04%.
- Across the five-year window, FCF Margin slumped 6089 bps in 2022 and soared 8254 bps in 2023, its largest moves.
- Year by year, FCF Margin stood at 62.37% in 2022, then surged by 70 bps to 18.5% in 2023, then slipped by 12 bps to 20.74% in 2024, then soared by 107 bps to 1.52% in 2025, then tumbled by 1899 bps to 27.27% in 2026.
- Per Business Quant, the three latest NPCE FCF Margin figures stand at 27.27% (Q1 2026), 1.52% (Q4 2025), and 7.17% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -1.28% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 37.67% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.68% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.18% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | NeuroPace | 494.96 Mn | 440.98 Mn | 18.05 Mn | -27.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.27% |
| Dec 31, 2025 | 1.52% |
| Sep 30, 2025 | -7.17% |
| Jun 30, 2025 | -9.51% |
| Mar 31, 2025 | -33.46% |
| Dec 31, 2024 | -20.74% |
| Sep 30, 2024 | -8.89% |
| Jun 30, 2024 | -20.98% |
| Mar 31, 2024 | -41.69% |
| Dec 31, 2023 | -18.50% |
| Sep 30, 2023 | -14.06% |
| Jun 30, 2023 | -26.66% |
| Mar 31, 2023 | -67.92% |
| Dec 31, 2022 | -62.37% |
| Sep 30, 2022 | -62.36% |
| Jun 30, 2022 | -109.21% |
| Mar 31, 2022 | -100.50% |
| Dec 31, 2021 | -77.20% |
| Sep 30, 2021 | -43.22% |
| Jun 30, 2021 | -48.31% |